Job title: Deputy Director for the Division of Hepatology & Nutrition (DHN)
Frank Anania is a hepatologist who is currently a medical reviewer in the Division of Gastroenterology and Inborn Errors Products (DGIEP) in the Office of New Drugs of the US Food and Drug Administration. Prior to joining the Agency in early 2018, Anania was a physician-scientist who conducted basic biomedical research for several decades in the area of hepatic fibrosis and non-alcoholic fatty liver disease.
Revisiting US FDA Regulatory Guidance for Developing Therapy for Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) with Liver Fibrosis: What’s New? 8:45 am
day: Day Two